Location History:
- Little Hadham, GB (2000)
- Ware, GB (2000 - 2001)
- Sandwich, GB (2004)
- Sandwich, Kent, CT13 9NJ, GB (2008)
- Harlow, GB (2006 - 2010)
- Essex, GB (2012)
Company Filing History:
5 out of 2,198 
3 out of 1,168 
1 out of 4,455 
Years Active: 2000-2012
Title: The Innovative Contributions of Desmond John Best
Introduction
Desmond John Best is a notable inventor based in Harlow, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Best has made strides in developing compounds that address various neurological and psychiatric conditions. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Among his latest patents is a piperazine derivative that exhibits an affinity for the histamine H3 receptor. This invention pertains to 1-(1-methylethyl)-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}piperazine or its pharmaceutically acceptable salts, particularly the hydrochloride salt. The patent details processes for preparing the compound, its compositions, and its applications in treating cognitive impairments, fatigue, and sleep disorders in mammals, including humans. Another notable patent involves macrolones, specifically amino substituted quinolones, which further showcases his innovative approach to pharmaceutical development.
Career Highlights
Desmond John Best has had a distinguished career, working with prominent companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has undoubtedly contributed to his expertise and success as an inventor in the pharmaceutical industry.
Collaborations
Throughout his career, Best has collaborated with esteemed colleagues, including Barry S. Orlek and Brian Charles Gasson. These partnerships have likely enriched his work and led to the development of groundbreaking inventions.
Conclusion
Desmond John Best's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of neurological and psychiatric diseases, showcasing the importance of innovation in healthcare.